81 Views | 49 Downloads
Study conception and design: B.A.M. and B.R.M. Acquisition of data: B.R.M. and M.S. Analysis and interpretation of data: R.P.S., J.J.R., A.M.S., S.H.S., B.A.M., and B.R.M. Drafting of manuscript: R.P.S., J.J.R., A.M.S., S.H.S., B.A.M., B.R.M., and K.M.G. Critical revision: B.A.M., S.H.S., A.M.S., B.R.M., K.M.G., R.P.S., and C.R.E. All authors have approved the manuscript submission. The content of this manuscript has not been published or submitted for publication elsewhere.
B.A.M. has received grant support from Genentech, Minnetronix Neuro, Biogen, Voyager Therapeutics, and Alcyone Lifesciences. B.A.M. is a scientific advisory board member for Alcyone Lifesciences and the Chiari and Syringomyelia Foundation, and serves as a consultant to SwanBio Therapeutics, Cerebral Therapeutics, Minnetronix Neuro, and CereVasc.
This study was funded by NASA Idaho Space Grant Consortium grant NNX10AM75H, NASA grant NNX16AT06G, National Institute of Neurological Disorders, and Stroke grant 1R01NS11128301, the Georgia Research Alliance, and the NASA Human Research Program.
© The Author(s) 2020